Summary by Moomoo AI
Panbela Therapeutics, Inc. held a special meeting of stockholders on May 28, 2024, where two key proposals were voted upon. The first proposal, which was to effect a reverse stock split of the company's common stock at a ratio between 1-for-10 and 1-for-45, was approved by stockholders with 47,410,136 votes for, 44,904,765 against, and 28,979 abstentions. The second proposal, concerning the adjournment of the special meeting to solicit additional proxies if necessary, was also approved. However, the adjournment was deemed unnecessary as a quorum was present and the reverse stock split proposal passed. The Board of Directors has yet to determine the specific timing or ratio for the reverse stock split. The meeting's outcomes were filed in a Form 8-K report with the Securities and Exchange Commission on May 29, 2024, by Susan Horvath of Panbela Therapeutics.